Nuveen
TNDM icon

Nuveen’s Tandem Diabetes Care TNDM Stock Holding History

Nuveen’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
157,066
-206,736
-57% -$3.61M ﹤0.01% 2492
2026
Q1 		$6.97M Sell
363,802
-199,472
-35% -$4.33M ﹤0.01% 1744
2025
Q4 		$12.4M Buy
563,274
+60,664
+12% +$1.09M ﹤0.01% 1430
2025
Q3 		$6.1M Sell
502,610
-125,887
-20% -$1.7M ﹤0.01% 1809
2025
Q2 		$11.7M Buy
628,497
+320,182
+104% +$6.34M ﹤0.01% 1417
2025
Q1 		$5.91M Sell
308,315
-210,704
-41% -$6.17M ﹤0.01% 1835
2024
Q4 		$18.7M Buy
519,019
+46,594
+10% +$1.58M 0.01% 1230
2024
Q3 		$20M Buy
472,425
+227,833
+93% +$9.66M 0.01% 1196
2024
Q2 		$9.85M Buy
244,592
+100,664
+70% +$4.2M ﹤0.01% 1583
2024
Q1 		$5.1M Sell
143,928
-1,173
-0.8% -$31.4K ﹤0.01% 1989
2023
Q4 		$4.29M Sell
145,101
-11,047
-7% -$229K ﹤0.01% 2064
2023
Q3 		$3.24M Sell
156,148
-29,301
-16% -$805K ﹤0.01% 2079
2023
Q2 		$4.55M Sell
185,449
-297,892
-62% -$9.58M ﹤0.01% 1969
2023
Q1 		$19.6M Sell
483,341
-53,631
-10% -$2.22M 0.01% 1062
2022
Q4 		$24.1M Buy
536,972
+59,318
+12% +$2.69M 0.01% 912
2022
Q3 		$22.9M Buy
477,654
+26,406
+6% +$1.45M 0.01% 930
2022
Q2 		$26.7M Buy
451,248
+102,427
+29% +$8.41M 0.01% 848
2022
Q1 		$39.6M Buy
348,821
+17,352
+5% +$2.03M 0.01% 745
2021
Q4 		$49.9M Buy
331,469
+5,838
+2% +$788K 0.01% 684
2021
Q3 		$38.9M Sell
325,631
-72,327
-18% -$7.97M 0.01% 832
2021
Q2 		$38.8M Buy
397,958
+41,306
+12% +$3.68M 0.01% 893
2021
Q1 		$31.5M Sell
356,652
-21,535
-6% -$2M 0.01% 1003
2020
Q4 		$36.2M Buy
378,187
+31,412
+9% +$3.24M 0.01% 878
2020
Q3 		$39.4M Buy
346,775
+50,704
+17% +$5.33M 0.02% 674
2020
Q2 		$29.3M Sell
296,071
-175,382
-37% -$14M 0.01% 807
2020
Q1 		$30.3M Sell
471,453
-23,702
-5% -$1.66M 0.01% 678
2019
Q4 		$29.5M Sell
495,155
-78,210
-14% -$4.82M 0.01% 947
2019
Q3 		$33.8M Buy
573,365
+269,645
+89% +$17.2M 0.01% 857
2019
Q2 		$19.6M Buy
+303,720
New +$19.6M 0.01% 1159

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Nuveen's TNDM Position: Q2 2026 in Review

Nuveen reduced its Tandem Diabetes Care (TNDM) stake by 57% in Q2 2026, selling an estimated $3.61M and leaving 157,066 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

Nuveen first reported a position in TNDM in Q2 2019 and has held it in 29 quarters since. The position peaked at $49.9M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Nuveen held 157,066 shares of Tandem Diabetes Care worth $2.37M as of Q2 2026.
  • Nuveen sold 206,736 Tandem Diabetes Care shares in Q2 2026, an estimated $3.61M.
  • Tandem Diabetes Care made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2492 holding.
  • Nuveen first reported a position in Tandem Diabetes Care in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Tandem Diabetes Care position peaked at $49.9M in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.